4 key drivers to accelerate your study start-up in 2020 and beyond
As we say goodbye to the 10’s and say hello to the 20’s, we at COUCH Health enter 2020 with enthusiasm and excitement for the what the future holds for clinical research.
After a lot of debate and discussion in the office, we have settled on 4 key areas that will play a part in accelerating your study start-up in 2020 and beyond.
Improving diversity of clinical trials
Improving diversity in clinical trial participation will be a particular focus for COUCH Health in 2020 as it’s not difficult to find cases of poor diversity in clinical trials, for instance, read this 2018 article in ProPublica that reported on US cancer drug trials. African Americans comprised less than 5% of trials for drugs approved in the past four years.
You are probably wondering what are the benefits of improving diversity in clinical studies? By enrolling minority patients in studies, the results of the studies will be relevant to more segments of the population, and data suggests that by improving access to clinical studies, we may well succeed in improving access to healthcare services generally. The outcome of this will be better health equity for everybody.
So, in 2020 and beyond, we would expect to see more diversity programs being developed by clinical study sponsors.
Improved patient engagement in clinical studies
Unfortunately, our industry still has not got patient engagement right, at COUCH Health we worry that our industry is paying lip-service to the patient. You may recall this epic rant by our director after attending a conference in 2019? In summary, there was concern that engaging with patients seems to be a tick-box exercise.
In 2020 and beyond, we would like to start seeing more MEANINGFUL patient engagement and using those insights to drive the clinical study experience forward. The benefits of involving the patient from a very early stage of the clinical study planning can lead to:
Faster patient recruitment.
Improved informed consent.
Less clinical study delays.
Improved reputation of studies.
If you think patient engagement is important and can accelerate your study start-up in 2020 and beyond then download this white paper to learn more.
Listen Listen Listen, then act
Even if we think we know what patients want, we don’t. So, it’s important to listen to them and be willing to take their feedback on board, so that your materials will be as relevant as possible. Plus, getting your patients involved at the beginning of the study, such as during the design process, allows them to gain a better understanding of the study. You can build a trusting partnership with patients, and it’s more likely they’ll be willing to take part.
So, why is it so important to get patient insights? Because if your motives and expectations of the study are different, and you’re just simply not on the same page about the outcomes of the study and what the materials should include, then it could hinder your patients’ involvement. And with low recruitment and retention rates being a current issue, if there are any steps that we can take to improve them, we should try!
We wrote a blog about the importance of social listening here… worth a read!
AI to improve patient recruitment?
2020 is shaping up to be very interesting indeed as we are beginning to see some innovation in the artificial intelligence and patient recruitment space. Imagine if as a site you could find patients within minutes not months? If you are a sponsor, you could work with the sites who will guarantee the patients you need! The artificial intelligence space is very exciting for that reason as it is possible. There is an innovative company based in the US who are doing exactly what we described above, using AI and language processing they can take the stress out of medical record reviews to find the desired patient within minutes. They are called Deep6 AI, check them out.